🇺🇸 FDA
Pipeline program

non-preserved sterile liquid formulation

CK-0045_CS02

Phase 2 small_molecule active

Quick answer

non-preserved sterile liquid formulation for Type 2 diabetes and Obesity is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Type 2 diabetes and Obesity
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials